Estrella Immunopharma is nearing completion of its New York listing using a SPAC backed by China's UP Fintech.The cancer therapy developer was only founded last year but thinks it can start generating...
Source LinkEstrella Immunopharma is nearing completion of its New York listing using a SPAC backed by China's UP Fintech.The cancer therapy developer was only founded last year but thinks it can start generating...
Source Link
Comments